Top Markets
#1 GEKKO GEKKO +51.79%
#2 ADO Protocol ADO Protocol +38.49%
#3 Helium Helium +33.05%
#4 Pons Pons +29.98%
#5 TENDIES TENDIES +21.40%
#6 龙虾 (Lobster) 龙虾 (Lobster) +20.56%
#7 o1.exchange o1.exchange +18.98%
#8 Giggle Fund Giggle Fund +18.51%
#9 Main Street Yield Main Street Yield +17.48%
#10 CZ'S Dog CZ'S Dog +16.11%
Coin of the day
GEKKO GEKKO
Settings
Language
ENGLISH
Currency
USD
Theme
Kolon TissueGene, Inc. Kolon TissueGene, Inc.

Kolon TissueGene, Inc.

950160
Rank in Stocks #9085
Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the... Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the advancement of clinical-stage cell-based treatments for osteoarthritis. Its flagship offering is TG-C, a proprietary platform technology that integrates allogeneic primary cells with genetically engineered counterparts. Established by Kwan H. Lee on June 9, 1999, the enterprise maintains its corporate headquarters in Rockville, Maryland.
Share Price
$12.94
Last synced: 2026-08-28
Market Cap
$1.10B
Change (1 day)
-0.16%
Change (1 year)
-51.50%
Country
US
Trade Kolon TissueGene, Inc. (950160)

Category

Healthcare
Stock split history for Kolon TissueGene, Inc. (950160)
Kolon TissueGene, Inc. stock (symbol: 950160) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 29, 2026.
One 950160 share bought prior to Aug 29, 2026 would equal to 0 950160 shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH